Amicus Therapeutics
FOLD
#3908
Rank
S$3.95 B
Marketcap
S$12.83
Share price
-0.50%
Change (1 day)
-1.80%
Change (1 year)

Amicus Therapeutics (FOLD) - Total assets

Total assets on the balance sheet as of September 2025 : S$1.12 Billion

According to Amicus Therapeutics 's latest financial reports the company's total assets are S$1.12 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Amicus Therapeutics - Total assets on balance sheet (from 2005 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$1.06 B3.87%
2023-12-31S$1.02 B5.82%
2022-12-31S$0.97 B-20.66%
2021-12-31S$1.22 B4.34%
2020-12-31S$1.17 B2.32%
2019-12-31S$1.14 B6.21%
2018-12-31S$1.07 B28.68%
2017-12-31S$0.83 B-44.11%
2016-12-31S$1.50 B16.79%
2015-12-31S$1.28 B363.14%
2014-12-31S$0.27 B71.66%
2013-12-31S$0.16 B20.05%
2012-12-31S$0.13 B48.94%
2011-12-31S$90.38 M-37.66%
2010-12-31S$0.14 B20.97%
2009-12-31S$0.11 B-34.92%
2008-12-31S$0.18 B-23.41%
2007-12-31S$0.24 B162.91%
2006-12-31S$91.45 M91.6%
2005-12-31S$47.73 M
2003-12-31S$0.85 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Biogen
BIIB
S$37.84 B 3,261.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$9.86 B 776.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.47 B-58.10%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$106.86 B 9,391.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
S$0.26 B-76.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
S$104.39 B 9,171.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark